1,051 results

1. pAAV-Ef1a-oScarlet (AAV8)

   Viral Prep

   #137135-AAV8

   Purpose

   Ready-to-use AAV8 particles produced from pAAV-Ef1a-oScarlet (#137135). In addition to the viral particles, you will also receive purified pAAV-Ef1a-oScarlet plasmid DNA. EF1a-driven expression of oScarlet. These AAV preparations are suitable purity for injection into animals.

   Depositor

   INTRSECT 2.0 Project, Karl Deisseroth

   Article

   Fenno et al Neuron. 2020 Jun 20. pii: S0896-6273(20)

   Promoter

   EF1a

   Tags

   oScarlet

   Available Since

   May 6, 2021

   Availability

   Academic Institutions and Nonprofits only

2. pENN.AAV.CMVs.TurboRFP.WPRE.RBG (AAV8)

   Viral Prep

   #105548-AAV8

   Purpose

   Ready-to-use AAV8 particles produced from pENN.AAV.CMVs.TurboRFP.WPRE.RBG (#105548). In addition to the viral particles, you will also receive purified pENN.AAV.CMVs.TurboRFP.WPRE.RBG plasmid DNA. CMV-driven TurboRFP expression. These AAV preparations are suitable purity for injection into animals.

   Depositor

   James M. Wilson

   Promoter

   CMV

   Tags

   TurboRFP

   Available Since

   June 29, 2018

   Availability

   Academic Institutions and Nonprofits only

3. AAV-EF1a-jGCaMP8m-WPRE (AAV Retrograde)

   Viral Prep

   #176757-AAVrg

   Purpose

   Ready-to-use AAV Retrograde particles produced from AAV-EF1a-jGCaMP8m-WPRE (#176757). In addition to the viral particles, you will also receive purified AAV-EF1a-jGCaMP8m-WPRE plasmid DNA. EF1a-driven expression of calcium sensor GCaMP8m. These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Loren Looger

   Promoter

   EF1a

   Available Since

   Sept. 27, 2023

   Availability

   Academic Institutions and Nonprofits only

4. pAAV-CAG-NIR-GECO2G (AAV2)

   Viral Prep

   #159605-AAV2

   Purpose

   Ready-to-use AAV2 particles produced from pAAV-CAG-NIR-GECO2G (#159605). In addition to the viral particles, you will also receive purified pAAV-CAG-NIR-GECO2G plasmid DNA. CAG-driven expression of the near-infrared calcium indicator NIR-GECO2G. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Robert Campbell

   Article

   Qian et al PLoS Biol. 2020 Nov 24;18(11):e3000965.

   Promoter

   CAG

   Available Since

   Dec. 18, 2024

   Availability

   Academic Institutions and Nonprofits only

5. AAV-CamKIIa-jGCaMP8s-WPRE (AAV Retrograde)

   Viral Prep

   #176752-AAVrg

   Purpose

   Ready-to-use AAV Retrograde particles produced from AAV-CamKIIa-jGCaMP8s-WPRE (#176752). In addition to the viral particles, you will also receive purified AAV-CamKIIa-jGCaMP8s-WPRE plasmid DNA. CamKIIa-driven expression of calcium sensor GCaMP8s. These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Loren Looger

   Promoter

   CamKIIalpha

   Available Since

   July 21, 2023

   Availability

   Academic Institutions and Nonprofits only

6. pTR-UF11 (AAV.A09.T)

   Viral Prep

   #157970-AAV.A09.T

   Purpose

   Ready-to-use AAV6 in TMN200 particles produced from pTR-UF11 (#157970). In addition to the viral particles, you will also receive purified pTR-UF11 plasmid DNA. 'Humanized' GFP driven by Chimeric CMV/Chicken Beta Actin promoter

   Depositor

   Sergei Zolotukhin

   Article

   Burger et al Mol Ther. 2004 Aug;10(2):302-17. doi: 10

   Promoter

   chimeric CMV/Chicken Beta actin (CBA)

   Tags

   GFP

   Available Since

   Dec. 21, 2020

   Availability

   Academic Institutions and Nonprofits only

7. pAAV-Ef1a-DIO C1V1 (t/t)-TS-EYFP (AAV9)

   Viral Prep

   #35497-AAV9

   Purpose

   Ready-to-use AAV9 particles produced from pAAV-Ef1a-DIO C1V1 (t/t)-TS-EYFP (#35497). In addition to the viral particles, you will also receive purified pAAV-Ef1a-DIO C1V1 (t/t)-TS-EYFP plasmid DNA. EFIa-driven, Cre-dependent, C1V1 (t/t) fused to EYFP for optogenetic activation. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Karl Deisseroth

   Article

   Yizhar et al Nature. 2011 Jul 27;477(7363):171-8. doi

   Promoter

   EF1a

   Tags

   EYFP (Cre-dependent)

   Available Since

   March 30, 2018

   Availability

   Academic Institutions and Nonprofits only

8. pAAV-hDlx-Flex-GFP-Fishell_6 (AAV Retrograde)

   Viral Prep

   #83895-AAVrg

   Purpose

   Ready-to-use AAV Retrograde particles produced from pAAV-hDlx-Flex-GFP-Fishell_6 (#83895). In addition to the viral particles, you will also receive purified pAAV-hDlx-Flex-GFP-Fishell_6 plasmid DNA. mDlx-driven, Cre-dependent expression of GFP. These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Gordon Fishell

   Article

   Dimidschstein et al Nat Neurosci. 2016 Oct 31. doi: 10.1038/

   Promoter

   hDlx

   Tags

   GFP

   Available Since

   March 2, 2020

   Availability

   Academic Institutions and Nonprofits only

9. pAAV-mDlx-NLS-mRuby2 (AAV2)

   Viral Prep

   #99130-AAV2

   Purpose

   Ready-to-use AAV2 particles produced from pAAV-mDlx-NLS-mRuby2 (#99130). In addition to the viral particles, you will also receive purified pAAV-mDlx-NLS-mRuby2 plasmid DNA. mDlx-driven NLS-mRuby2 expression. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Viviana Gradinaru

   Article

   Chan et al Nat Neurosci. 2017 Aug;20(8):1172-1179.

   Promoter

   mDLX5/6

   Tags

   mRuby2

   Available Since

   Sept. 27, 2023

   Availability

   Academic Institutions and Nonprofits only

10. pAAV-nEF-NpHR3.3-EYFP (AAV8)

    Viral Prep

    #137151-AAV8

    Purpose

    Ready-to-use AAV8 particles produced from pAAV-nEF-NpHR3.3-EYFP (#137151). In addition to the viral particles, you will also receive purified pAAV-nEF-NpHR3.3-EYFP plasmid DNA. nEF-driven expression of NpHR3.3-EYFP for optogenetic inhibition. These AAV preparations are suitable purity for injection into animals.

    Depositor

    INTRSECT 2.0 Project, Karl Deisseroth

    Article

    Fenno et al Neuron. 2020 Jun 20. pii: S0896-6273(20)

    Promoter

    nEF

    Tags

    EYFP

    Available Since

    May 5, 2021

    Availability

    Academic Institutions and Nonprofits only